Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Alzheimer Disease × Rosiglitazone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Solid Cancers 1 Sezary Syndrome 1 Polycystic Ovary Syndrome 1 Pituitary Neoplasms 1 Mycosis Fungoides 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Follicular 1 Central Nervous System Neoplasms 1 Alzheimer Disease 1

Interventions

birtamimab 1 Rosiglitazone 1 Melphalan 1 Magnetic Resonance Imaging 1 Dexamethasone 1 Control Groups 1 Calcium Dobesilate 1 Bortezomib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

GlaxoSmithKline

Phase 3 Completed

862 enrolled 36 charts

Alzheimer Disease, Lymphoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡